These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 17883957

  • 1. Population pharmacokinetics of valproate in Chinese children with epilepsy.
    Jiang DC, Wang L, Wang YQ, Li L, Lu W, Bai XR.
    Acta Pharmacol Sin; 2007 Oct; 28(10):1677-84. PubMed ID: 17883957
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pharmacokinetic modeling of valproate from clinical data in Serbian epileptic patients.
    Jankovic SM, Milovanovic JR.
    Methods Find Exp Clin Pharmacol; 2007 Dec; 29(10):673-9. PubMed ID: 18200330
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacokinetic modeling of carbamazepine based on clinical data from Serbian epileptic patients.
    Jankovic SM, Jovanovic D, Milovanovic JR.
    Methods Find Exp Clin Pharmacol; 2008 Nov; 30(9):707-13. PubMed ID: 19229380
    [Abstract] [Full Text] [Related]

  • 8. Population pharmacokinetic models of lamotrigine in different age groups of Chinese children with epilepsy.
    Zhang ZB, Ji SM, Han Y, Zang LL, Wang YH, Lu W, Wang L, Wu Y.
    Eur J Clin Pharmacol; 2017 Apr; 73(4):445-453. PubMed ID: 28064355
    [Abstract] [Full Text] [Related]

  • 9. Nonparametric population modeling of valproate pharmacokinetics in epileptic patients using routine serum monitoring data: implications for dosage.
    Bondareva IB, Jelliffe RW, Sokolov AV, Tischenkova IF.
    J Clin Pharm Ther; 2004 Apr; 29(2):105-20. PubMed ID: 15068399
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Population pharmacokinetics of valproic acid in epileptic children: Effects of clinical and genetic factors.
    Xu S, Chen Y, Zhao M, Guo Y, Wang Z, Zhao L.
    Eur J Pharm Sci; 2018 Sep 15; 122():170-178. PubMed ID: 29981400
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacokinetic parameters of total and unbound valproic acid and their relationships to seizure control in epileptic children.
    Panomvana Na Ayudhya D, Suwanmanee J, Visudtibhan A.
    Am J Ther; 2006 Sep 15; 13(3):211-7. PubMed ID: 16772762
    [Abstract] [Full Text] [Related]

  • 14. Poor applicability of estimation method for adults to calculate unbound serum concentrations of valproic acid in epileptic neonates and infants.
    Ueshima S, Aiba T, Ishikawa N, Sato T, Kawasaki H, Kurosaki Y, Ohtsuka Y, Sendo T.
    J Clin Pharm Ther; 2009 Aug 15; 34(4):415-22. PubMed ID: 19583674
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Development of a population pharmacokinetic model for carbamazepine based on sparse therapeutic monitoring data from pediatric patients with epilepsy.
    Carlsson KC, Hoem NO, Glauser T, Vinks AA.
    Clin Ther; 2005 May 15; 27(5):618-26. PubMed ID: 15978311
    [Abstract] [Full Text] [Related]

  • 18. Valproate population pharmacokinetics in children.
    Serrano BB, García Sánchez MJ, Otero MJ, Buelga DS, Serrano J, Domínguez-Gil A.
    J Clin Pharm Ther; 1999 Feb 15; 24(1):73-80. PubMed ID: 10319910
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetic modelling of valproic acid from routine clinical data in Egyptian epileptic patients.
    EL Desoky ES, Fuseau E, EL Din Amry S, Cosson V.
    Eur J Clin Pharmacol; 2004 Jan 15; 59(11):783-90. PubMed ID: 14673555
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.